Results of individual studies | 20 | For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot. | Table 3 Figure 3 & 4 3-4 |
Synthesis of results | 21 | Present results of each meta-analysis done, including confidence intervals and measures of consistency. | Table 2 Figure 2 4 |
Risk of bias across studies | 22 | Present results of any assessment of risk of bias across studies (see Item 15). | 4 |
Additional analysis | 23 | Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item 16]). | 3 - 4 |
DISCUSSION |
| ||
Summary of evidence | 24 | Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers). | 4 - 5 |
Limitations | 25 | Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias). | 4 |
Conclusions | 26 | Provide a general interpretation of the results in the context of other evidence, and implications for future research. | 4 - 5 |
FUNDING |
| ||
Funding | 27 | Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review. | 5 |